Results 11 to 20 of about 25,279 (271)

Levodopa intolerance as a potential clinical red flag for neuronal intranuclear inclusion disease (NIID) in atypical parkinsonism: a case report [PDF]

BMC Neurology
Background Neuronal intranuclear inclusion disease (NIID) is a rare, progressive multisystem disorder most commonly associated with GGC repeat expansion in the NOTCH2NLC gene.
Peixi Zang, Ying Liu, Yunfei Hao
doaj   +2 more sources

The Role of the Evans Index and the Maximal Width of the Frontal Horns of the Lateral Ventricles in the Diagnostic Imaging of Progressive Supranuclear Palsy and Multiple-System Atrophy

Diagnostics, 2023
Progressive Supranuclear Palsy and Multiple-System Atrophy are entities within the spectrum of atypical parkinsonism. The role of imaging methods in the diagnosis and differentiation between PSP and MSA is limited and Magnetic Resonance Imaging (MRI) is ...
Michał Kutyłowski, Piotr Alster, Natalia Madetko-Alster, Anna Marta Migda, Leszek Królicki, Bartosz Migda   +5 more
doaj   +1 more source

Autopallidotomy: From Colloquial Term to Scientific Theory

Journal of Parkinson’s Disease, 2022
Levodopa-induced dyskinesia (LID), a frequent complication of Parkinson’s disease (PD), occurs in ∼30% of patients after five years’ treatment with levodopa. In atypical parkinsonism, LID occurs less frequently than in PD.
Stuart J. McCarter, Rodolfo Savica
doaj   +1 more source

TARDBP mutations in a cohort of Italian patients with Parkinson’s disease and atypical parkinsonisms

Frontiers in Aging Neuroscience, 2022
BackgroundAggregates of TAR DNA-binding protein of 43 kDa (TDP-43) represent the pathological hallmark of most amyotrophic lateral sclerosis (ALS) and of nearly 50% of frontotemporal dementia (FTD) cases but were also observed to occur as secondary ...
Cinzia Tiloca, Stefano Goldwurm, Narghes Calcagno, Narghes Calcagno, Federico Verde, Federico Verde, Silvia Peverelli, Daniela Calini, Anna Lena Zecchinelli, Davide Sangalli, Davide Sangalli, Antonia Ratti, Antonia Ratti, Gianni Pezzoli, Vincenzo Silani, Vincenzo Silani, Nicola Ticozzi, Nicola Ticozzi   +17 more
doaj   +1 more source

The Strengths and Obstacles in the Differential Diagnosis of Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P) and Multiple System Atrophy (MSA) Using Magnetic Resonance Imaging (MRI) and Perfusion Single Photon Emission Computed Tomography (SPECT)

Diagnostics, 2022
Multiple System Atrophy—Parkinsonism Predominant (MSA-P) and Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P) are the clinical manifestations of atypical parkinsonism. Currently, there are no efficient in vivo methods available relating to
Piotr Alster, Michał Nieciecki, Bartosz Migda, Michał Kutyłowski, Natalia Madetko, Karolina Duszyńska-Wąs, Ingeborga Charzyńska, Dariusz Koziorowski, Leszek Królicki, Andrzej Friedman   +9 more
doaj   +1 more source

Neurological manifestations of glutamic acid decarboxylase autoimmunity in Indian patients

Annals of Indian Academy of Neurology, 2023
Objective: To study the neurological manifestations of glutamic acid decarboxylase (GAD 65) autoimmunity in Indian patients. Methods: Retrospective study conducted in a tertiary care referral hospital in South India.
Meena Thevarkalam, Sudheeran Kannoth, Vivek Nambiar, Siby Gopinath, Annamma Mathai, Anandkumar Anandakuttan, Sajitha Krishnan, Renjitha Bhaskaran   +7 more
doaj   +1 more source

Atypical Antipsychotics and Parkinsonism [PDF]

Archives of Internal Medicine, 2005
Atypical antipsychotic agents are thought to be less likely than older typical agents to produce parkinsonism. This has not been well documented. We compared the risk of development of incident parkinsonism among older adults dispensed atypical relative to typical antipsychotics.Retrospective cohort study of all adults 66 years and older in Ontario. We
Rochon, Paula A., Stukel, Therese A., Sykora, Kathy, Gill, Sudeep S., Garfinkel, Susan, Anderson, Geoffrey M., Normand, Sharon-Lise T., Mamdani, Muhammad M., Lee, Philip E., Li, Ping, Bronskill, Susan E., Marras, Connie, Gurwitz, Jerry H.   +12 more
openaire   +3 more sources

Neuropsychiatric disturbances in atypical Parkinsonian disorders [PDF]

, 2018
Multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD) are the most common atypical parkinsonisms. These disorders are characterized by varying combinations of autonomic, cerebellar and pyramidal system ...
Belvisi, Daniele, Berardelli, Isabella, Fabbrini, Andrea, Fabbrini, Giovanni, Pasquini, Massimo, Pompili, Maurizio, Suppa, Antonio   +6 more
core   +1 more source

Retracted: Atypical parkinsonism and self‐mutilation: A new lens on the old concept

Clinical Case Reports, 2021
We report a case of atypical parkinsonism and self‐mutilation.
Mehri Salari, Masoud Etemadifar, Kimia Ghanbari   +2 more
doaj   +1 more source

Parkinson's disease biomarkers: perspective from the NINDS Parkinson's Disease Biomarkers Program [PDF]

, 2017
Biomarkers for Parkinson's disease (PD) diagnosis, prognostication and clinical trial cohort selection are an urgent need. While many promising markers have been discovered through the National Institute of Neurological Disorders and Stroke Parkinson's ...
Albin, Roger, Alcalay, Roy N., Babcock, Debra, Bowman, F. DuBois, Chen-Plotkin, Alice, David, Karen K., Dawson, Ted M., Dewey, Richard B., Jr., Foroud, Tatiana, German, Dwight, Gwinn, Katrina, Huang, Xuemei, Lungu, Codrin, Petyuk, Vlad, Potashkin, Judith A., Rosenthal, Liana S., Saunders-Pullman, Rachel, Scherzer, Clemens R., Sieber, Beth-Anne, St Hillaire-Clarke, Coryse, Sutherland, Margaret, Swanson-Fischer, Christine, Vaillancourt, David E., Walt, David R., West, Andrew B., Zhang, Jing   +25 more
core   +1 more source